Recently, Pimentel et al. demonstrated the benefits of using anti-CdtB and anti-vinculin antibodies as biomarkers to distinguish patients with IBS-D from those with IBD in the workup of diarrhea (Pimentel et al., 2015b). This evidence concerns the gene VCL and irritable bowel syndrome.